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Clinics and pathology 
Disease 
Myelodysplastic syndrome (MDS) 
Epidemiology 
Only 1 case to date: a 33 yr old female patient with 
RAEB1. 
Cytogenetics 
Sole anomaly in this patient. 
Prognosis 
The patient remains asymptomatic 5 yr after 
presentation. 





Probable role in regulation of cell proliferation 
(transcriptional regulation of cell cycle and DNA repair 
genes. 




HMGA2 exon 3 spliced to intron 3 of the gene. 
Fusion protein 
Description 
Truncated HMGA2 (normal exons 1 to 3 followed by 
12 amino acids from intron 3); ectopic expression of 
HMGA2. 
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